Localization of Neutrophil-Activating Peptide-1/Interleukin-8-Immunoreactivity in Normal and Psoriatic Skin
- 1 January 1991
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 96 (1), 26-30
- https://doi.org/10.1111/1523-1747.ep12514689
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNFCytokine, 1989
- The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.The Journal of Experimental Medicine, 1989
- Novel neutrophil-stimulating peptidesImmunology Today, 1989
- The Neutrophil-Activating Protein (NAP-1) Is Also Chemotactic for T LymphocytesScience, 1989
- Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1988
- A novel neutrophil-activating factor produced by human mononuclear phagocytes.The Journal of Experimental Medicine, 1988
- A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.The Journal of Experimental Medicine, 1988
- Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP)Biochemical and Biophysical Research Communications, 1988
- Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).The Journal of Experimental Medicine, 1987
- Identification of C5ades arg and an Anionic Neutrophil-Activating Peptide (ANAP) in Psoriatic ScalesJournal of Investigative Dermatology, 1986